About the Company
Novartis was founded in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis has two divisions - Innovative Medicines and Sandoz. Innovative Medicines Division commercializes innovative patented medicines to enhance health of patients whereas Sandoz is a well-known firm working in the generic pharmaceuticals domain and help people across the world. The purpose of the Novartis is to reimagine medicine to improve people's lives and use innovative science and technology to address challenging healthcare issues. Novartis discovers and develops breakthrough treatments to deliver them with aim to reward even investors. The company that aim to become the most valued and trusted global medicines company presently has 200 plus projects under its clinical pipeline. Novartis is known for investing huge amounts in research and development consistently. The company’s products reach nearly 1 billion people globally and nearly 125 000 people over140 nationalities work at Novartis across the world. Novartis ranks #4 in Fortune Magazine’s Most Admired Companies Pharmaceutical Industry list.